Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer “naturaceuticals”

This article was originally published in The Tan Sheet

Executive Summary

Consumer Healthcare division working with Global R&D on "'naturaceuticals,' effective natural products that might be difficult to develop as an Rx molecule, but might come to market relatively quickly under OTC or food supplement regulations," Consumer Healthcare Head Maurice Renshaw says in recent Pfizer employee newsletter. Pfizer's only U.S. supplement offerings are Halls Defense Supplement Drops; firm discontinued Quanterra supplement line in September 2000 due to low sales (1"The Tan Sheet" Oct. 2, 2000, In Brief). Renshaw says addition of Pharmacia's consumer healthcare business will add "geographic presence in important areas, including Western Europe - particularly the Nordic region - and Japan." Pfizer's acquisition of Pharmacia is expected to close by year-end...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094486

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel